Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

By Wu N   Chen S   Boulanger L   Rao P   Zhao Y  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1131-1139

Informa Healthcare

Access to resources Recommend Favorite

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis

By Nasr Samya Z.  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States

By Sun Shawn X.   Liu Gordon G.   Christensen Dale B.   Fu Alex Z.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2305-2312

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics

By  

Current Drug Safety, Vol. 9, Iss. 3, 2014-11 ,pp. : 227-235

Bentham Science Publishers

Access to resources Recommend Favorite

Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls

By Zhao Yang   Ye Wenyu   Le Trong K.   Boye Kristina S.   Holcombe John H.   Swindle Ralph  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 585-597

Informa Healthcare

Access to resources Recommend Favorite